# Civista Bancshares, Inc.: overview

CIVB · Nasdaq · CIK 944745 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/civb.md) · [Financials](/companies/civb/financials.md) · [Filings](/companies/civb/filings.md) · [Insiders](/companies/civb/insiders.md)

Latest reported revenue: [$5.7m](/filings/0001193125-26-338386.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 6, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001193125-26-338386).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $k | [5,194](/filings/0001193125-25-267194.md) | [2,469 d](/filings/0001193125-26-096836.md) | [4,795](/filings/0001193125-26-214922.md) | [5,107](/filings/0001193125-26-338386.md) | [6,181](/filings/0001193125-25-267194.md) | [2,968 d](/filings/0001193125-26-096836.md) | [4,815](/filings/0001193125-26-214922.md) | [5,660](/filings/0001193125-26-338386.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [161.1%](/filings/0001193125-25-267194.md) | [400.7% d](/filings/0001193125-26-096836.md) | [212.1%](/filings/0001193125-26-214922.md) | [215.7%](/filings/0001193125-26-338386.md) | [206.4%](/filings/0001193125-25-267194.md) | [413.4% d](/filings/0001193125-26-096836.md) | [311.3%](/filings/0001193125-26-214922.md) | [252.9%](/filings/0001193125-26-338386.md) |
| Diluted EPS | $ per share | [0.53](/filings/0001193125-25-267194.md) | not reported | [0.66](/filings/0001193125-26-214922.md) | [0.71](/filings/0001193125-26-338386.md) | [0.68](/filings/0001193125-25-267194.md) | not reported | [0.72](/filings/0001193125-26-214922.md) | [0.69](/filings/0001193125-26-338386.md) |
| Free cash flow | $k | not reported | not reported | [3,451](/filings/0001193125-26-214922.md) | not reported | not reported | not reported | not reported | not reported |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [19.6](/filings/0000950170-24-031472.md) | [24.5](/filings/0000950170-25-035961.md) | [30.4](/filings/0001193125-26-096836.md) | [19.1](/filings/0001193125-26-096836.md) | [19.0](/filings/0001193125-26-096836.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [206.5%](/filings/0000950170-24-031472.md) | [160.7%](/filings/0000950170-25-035961.md) | [141.1%](/filings/0001193125-26-096836.md) | [165.7%](/filings/0001193125-26-096836.md) | [242.9%](/filings/0001193125-26-096836.md) |
| Diluted EPS | $ per share | [2.63](/filings/0000950170-24-031472.md) | [2.60](/filings/0000950170-25-035961.md) | [2.73](/filings/0001193125-26-096836.md) | [2.01](/filings/0001193125-26-096836.md) | [2.64](/filings/0001193125-26-096836.md) |
| Free cash flow | $m | [38.8](/filings/0000950170-24-031472.md) | [18.7](/filings/0000950170-25-035961.md) | [59.3](/filings/0001193125-26-096836.md) | [44.1](/filings/0001193125-26-096836.md) | [42.1](/filings/0001193125-26-096836.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/civb/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $48.0m | 1,702,436 |  | Added +214,836 |
| [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $35.5m | 1,259,065 |  | Reduced −78,523 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $28.9m | 1,025,247 |  | Added +74,917 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $25.0m | 885,162 |  | Added +22,715 |
| [ALLIANCEBERNSTEIN L.P.](/funds/1109448.md) | 2026-06-30 | $20.5m | 899,109 |  | Reduced −46,606 |
| [MANUFACTURERS LIFE INSURANCE COMPANY, THE](/funds/928047.md) | 2026-06-30 | $16.1m | 570,879 |  | Reduced −3,918 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $15.7m | 555,485 |  | Added +155,477 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $15.5m | 548,033 |  | Added +60,281 |
| [ENDEAVOUR CAPITAL ADVISORS INC](/funds/1218749.md) | 2026-06-30 | $14.6m | 516,376 |  | Reduced −104,499 |
| [ROYCE & ASSOCIATES LP](/funds/906304.md) | 2026-06-30 | $11.0m | 391,417 |  | Reduced −1,943 |

## Recent filings

[All 1,557 filings](/companies/civb/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 16:04 ET | [8-K](/filings/0001193125-26-441630.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-441630 |
| 2026-10-23 | 16:15 ET | [8-K](/filings/0001193125-26-430445.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-430445 |
| 2026-10-22 | 07:15 ET | [8-K](/filings/0001193125-26-428313.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-428313 |
| 2026-10-21 | 17:00 ET | [8-K](/filings/0001193125-26-427956.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-427956 |
| 2026-10-01 | 07:30 ET | [8-K](/filings/0001193125-26-409817.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-409817 |
| 2026-09-18 | 17:00 ET | [8-K](/filings/0001193125-26-395696.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-395696 |
| 2026-09-15 | 17:00 ET | [8-K](/filings/0001193125-26-392096.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-392096 |
| 2026-08-31 | 07:45 ET | [8-K](/filings/0001193125-26-375432.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-26-375432 |
| 2026-08-06 | 17:01 ET | [10-Q](/filings/0001193125-26-338386.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338386 |
| 2026-07-24 | 16:30 ET | [8-K](/filings/0001193125-26-316153.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-316153 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-096836.md), filed Mar 6, 2026.

## Forecast league

Not in this season’s league. [This season’s league](/leagues.md)

## About the filer

- CIK: 944745
- Tickers: CIVB
- Exchange: Nasdaq
- SIC code: 6022 State Commercial Banks
- State of incorporation: OH
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 16:12 ET. No prices; not investment advice.